The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Macrophage Differentiation to Foam Cells
Abstract
Foam cell formation from macrophages with subsequent fatty streak formation plays a key role in early atherogenesis. Foam cell formation is thought to be induced by Low Density Lipoproteins (LDL), including oxidized LDL (OxLDL) or minimally modified LDL (mmLDL). Understanding the molecular mechanisms involved in OxLDL- and mmLDL-induced foam cell formation is of fundamental importance for atherosclerosis and cardiovascular disease. The expression of many genes is likely modulated during macrophage transformation into a foam cell. In this mini-review we describe functional consequences of modulation of three groups of genes: Scavenger Receptors (SR-A, CLA-1/SR-BI, CD36, CD68, LOX-1, and SR-PSOX), the PPAR family of nuclear receptors, and a number of genes involved in eicosanoid biosynthesis, including lipoxygenases and leukotriene receptors. Scavenger receptors appear to play a key role in uptake of OxLDL, while mmLDL appears to interact with CD14/TLR4. The regulation of scavenger receptors is, in part, mediated by the PPAR family of nuclear receptors. PPARalpha and PPARgamma agonists, such as thiazolidinediones and fibrates, and PPARdelta agonists were tested as atheroprotective drugs and showed some beneficial effects. Eicosanoids are naturally occuring agonists for PPARs. Recent observations indicate a role of the components of the eicosanoid cascade, such as 5-lipoxygenase, 15-lipoxygenase and the leukotriene receptors in foam cell formation. Selective inhibitors of lipoxygenases and leukotriene receptors could be useful in the treatment of atherosclerosis by preventing or reducing foam cell formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,668
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170 · cited 2×
“Some observations show that PPARα and PPARγ do not influence AcLDL-induced FC formation of human macrophages and may just activate ABCA1-mediated cholesterol efflux [151].”
BackgroundWang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S., Silverstein, R., Hoff, H. F., & Freeman, M. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209649200 · Cited by 1,028
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
Murphy, R. C., Hammarström, S., & Samuelsson, B. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4275 · Cited by 991
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 947
Monocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux
Ji, Y., Jian, B., Wang, N., Sun, Y., Moya, M. D. L. L., Phillips, M. C., Rothblat, G. H., Swaney, J. B., & Tall, A. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20982 · Cited by 694
Schwartz, L., Bourassa, M. G., Lespérance, J., Aldridge, H. E., Kazim, F., Salvatori, V. A., Henderson, M., Bonan, R., & David, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182603 · Cited by 692
A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
Matloubian, M., David, A., Engel, S., Ryan, J. E., & Cyster, J. G. (2000) · Nature Immunology · doi:10.1038/79738 · Cited by 661
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Heise, C. E., O'Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D.-S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003490200 · Cited by 658
Liver X Receptor Signaling Pathways in Cardiovascular Disease
Tontonoz, P., & Mangelsdorf, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0061 · Cited by 633
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580
Genetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., & Loskutoff, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6998 · Cited by 543
A Second Leukotriene B4 Receptor, Blt2
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 538
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523 · cited 1×
“Deletion of 12/15-LO reduces atherogenesis in ApoE-knockout mice [99].”
BackgroundImportance of Different Pathways of Cellular Cholesterol Efflux
Yancey, P. G., Bortnick, A. E., Kellner-Weibel, G., de la Llera-Moya, M., Phillips, M. C., & Rothblat, G. H. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000057572.97137.dd · Cited by 507
Castrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M., Fogelman, A. M., Cheng, G., & Tontonoz, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00384-8 · Cited by 488
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 458
Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki, H., Murase, T., Sawamura, T., Masaki, T., Hashimoto, N., & Kita, T. (1999) · Circulation · doi:10.1161/01.cir.99.24.3110 · Cited by 443
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182199799 · Cited by 438
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422 · cited 2×
“Even heterozygous 5-LO mice showed a dramatic decrease in aortic lesion development [73].”
BackgroundA role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
Parthasarathy, S., Wieland, E., & Steinberg, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.1046 · Cited by 415
Role of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
Miles, P. D. G., Barak, Y., He, W., Evans, R. M., & Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8538 · Cited by 400
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 399
15-Deoxy-Δ12,14-prostaglandin J2
Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110314200 · Cited by 392
Cytochrome P450 and Vascular Homeostasis
Fleming, I. (2001) · Circulation Research · doi:10.1161/hh2101.099268 · Cited by 383
Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y.-H., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368
Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
Konstam, M. A., Weir, M. R., Reicin, A., Shapiro, D., Sperling, R. S., Barr, E., & Gertz, B. J. (2001) · Circulation · doi:10.1161/hc4401.100078 · Cited by 352
Scavenger Receptors, Oxidized LDL, and Atherosclerosis
BOULLIER, A., BIRD, D. A., CHANG, M., DENNIS, E. A., FRIEDMAN, P., GILLOTTE‐TAYLOR, K., HÖRKKÖ, S., PALINSKI, W., QUEHENBERGER, O., SHAW, P., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03943.x · Cited by 330
Oxidized low-density lipoprotein-induced apoptosis
Salvayre, R., Auge, N., Benoist, H., & Negre-Salvayre, A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00343-8 · Cited by 330
Hubacek, J. A., Pit’ha, J., Škodová, Z., Stanĕk, V., & Poledne, R. (1999) · Circulation · doi:10.1161/01.cir.99.25.3218 · Cited by 327
Terasaka, N., Hiroshima, A., Koieyama, T., Ubukata, N., Morikawa, Y., Nakai, D., & Inaba, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03578-0 · Cited by 326
Baker, C. S. R., Hall, R. J. C., Evans, T. J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M. H., & Polak, J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.646 · Cited by 296
Peroxisome Proliferators Enhance Cyclooxygenase-2 Expression in Epithelial Cells
Meade, E. A., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8328 · Cited by 293
Lee, H., Shi, W., Tontonoz, P., Wang, S., Subbanagounder, G., Hedrick, C. C., Hama, S., Borromeo, C., Evans, R. M., Berliner, J. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.6.516 · Cited by 292
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
Brink, C., Dahlén, S.-E., Drazen, J., Evans, J. F., Hay, D. W. P., Nicosia, S., Serhan, C. N., Shimizu, T., & Yokomizo, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.8 · Cited by 286
Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 279
PPARγ and the Treatment of Insulin Resistance
OLEFSKY, J., & SALTIEL, A. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00306-4 · Cited by 279
Role of Oxidized LDL in Atherosclerosis
KITA, T., KUME, N., MINAMI, M., HAYASHIDA, K., MURAYAMA, T., SANO, H., MORIWAKI, H., KATAOKA, H., NISHI, E., HORIUCHI, H., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03941.x · Cited by 277
Feedback control of cyclooxygenase-2 expression through PPARγ
Inoue, H., Tanabe, T., & Umesono, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001387200 · Cited by 276 · cited 2×
“Expression of COX-2 in macrophages was suggested to be regulated by a negative feedback loop mediated through PPARγ, which makes possible a dynamic production of PG [179].”
BackgroundMechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
Heinecke, J. W. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00005 · Cited by 273
Davies, S. S., Pontsler, A. V., Marathe, G. K., Harrison, K. A., Murphy, R. C., Hinshaw, J. C., Prestwich, G. D., Hilaire, A. S., Prescott, S. M., Zimmerman, G. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100878200 · Cited by 266
Wang, N., & Tall, A. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000075912.83860.26 · Cited by 258
Cyrus, T., Sung, S., Zhao, L., Funk, C. D., Tang, S., & Praticò, D. (2002) · Circulation · doi:10.1161/01.cir.0000027816.54430.96 · Cited by 247
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice
Aiello, R. J., Bourassa, P.-A., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247
Feng, J., Han, J., Pearce, S. F. A., Silverstein, R. L., Gotto, A. M., Hajjar, D. P., & Nicholson, A. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32377-4 · Cited by 241
Cayatte, A. J., Du, Y., Oliver-Krasinski, J., Lavielle, G., Verbeuren, T. J., & Cohen, R. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1724 · Cited by 237
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Tordjman, K., Bernal-Mizrachi, C., Zemany, L., Weng, S., Feng, C., Zhang, F., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11497 · Cited by 229
Wang, Y., & Oram, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109977200 · Cited by 225
Phospholipase A2in Vascular Disease
Hurt-Camejo, E., Camejo, G., Peilot, H., Öörni, K., & Kovanen, P. (2001) · Circulation Research · doi:10.1161/hh1601.095598 · Cited by 219
Hydroxyeicosanoids Bind to and Activate the Low Affinity Leukotriene B4 Receptor, BLT2
Yokomizo, T., Kato, K., Hagiya, H., Izumi, T., & Shimizu, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011361200 · Cited by 205
Oxidized low density lipoprotein and innate immune receptors
Miller, Y. I., Chang, M.-K., Binder, C. J., Shaw, P. X., & Witztum, J. L. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00004 · Cited by 201
Napoli, C., Quehenberger, O., De Nigris, F., Abete, P., Glass, C. K., & Palinski, W. (2000) · The FASEB Journal · doi:10.1096/fj.99-0986com · Cited by 199
Lipoxygenase genes and their targeted disruption
Funk, C. D., Chen, X.-S., Johnson, E. N., & Zhao, L. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00036-9 · Cited by 194
Takahashi, K., Takeya, M., & Sakashita, N. (2002) · Medical Electron Microscopy · doi:10.1007/s007950200023 · Cited by 192
Fu, Y., Luo, N., Lopes-Virella, M. F., & Garvey, W. T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00305-2 · Cited by 185
Subbanagounder, G., Wong, J. W., Lee, H., Faull, K. F., Miller, E., Witztum, J. L., & Berliner, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107602200 · Cited by 183
Minami, M., Kume, N., Shimaoka, T., Kataoka, H., Hayashida, K., Akiyama, Y., Nagata, I., Ando, K., Nobuyoshi, M., Hanyuu, M., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.096652 · Cited by 175
A novel role for phospholipase A 2 isoforms in the checkpoint control of acute inflammation
Gilroy, D. W., Newson, J., Sawmynaden, P., Willoughby, D. A., & Croxtall, J. D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0837com · Cited by 174
Macrophage scavenger receptors and foam cell formation
de Villiers, W. J. S., & Smart, E. J. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.740 · Cited by 172
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Stefansson, S., McMahon, G., Petitclerc, E., & Lawrence, D. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454621 · Cited by 169
Macrophage Foam Cell Formation with Native Low Density Lipoprotein
Kruth, H. S., Huang, W., Ishii, I., & Zhang, W.-Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205059200 · Cited by 167
Sato, O., Kuriki, C., Fukui, Y., & Motojima, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110158200 · Cited by 166
Unkelbach, K., Gardemann, A., Kostrzewa, M., Philipp, M., Tillmanns, H., & Haberbosch, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.932 · Cited by 160
Yokode, M., Kita, T., Kikawa, Y., Ogorochi, T., Narumiya, S., & Kawai, C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113377 · Cited by 156
CD1 Expression in Human Atherosclerosis
Melián, A., Geng, Y., Sukhova, G. K., Libby, P., & Porcelli, S. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65176-0 · Cited by 150
Marathe, S. V., Kuriakose, G., Williams, K. J., & Tabas, I. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2648 · Cited by 146
Yoshimoto, T., & Takahashi, Y. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00034-5 · Cited by 140
Molecular biology of prostanoid receptors; an overview
Ushikubi, F., Hirata, M., & Narumiya, S. (1995) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/0929-7855(95)00022-i · Cited by 140
Shi, W., Wang, N. J., Shih, D. M., Sun, V. Z., Wang, X., & Lusis, A. J. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1078 · Cited by 139
12/15-Lipoxygenase, Oxidative Modification of LDL and Atherogenesis
Cyrus, C. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00096-2 · Cited by 139
Do Pathogens Accelerate Atherosclerosis?
Streblow, D. N., Nelson, J. A., & Orloff, S. L. (2001) · Journal of Nutrition · doi:10.1093/jn/131.10.2798s · Cited by 138
Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist?
Cullen, P., Baetta, R., Bellosta, S., Bernini, F., Chinetti, G., Cignarella, A., von Eckardstein, A., Exley, A., Goddard, M. J., Hofker, M. H., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000060200.73623.f8 · Cited by 137
Role of CD36, the Macrophage Class B Scavenger Receptor, in Atherosclerosis
NICHOLSON, A. C., Han, J., Febbraio, M., SILVERSTERIN, R. L., & Hajjar, D. P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03944.x · Cited by 136
Cyclooxygenase-2 In Human Pathological Disease
Koki, A. T., Khan, N., Woerner, B. M., Dannenberg, A. J., OLSON, L. M., Seibert, K., Edwards, D. A., Hardy, M. M., Isakson, P. C., & Masferrer, J. L. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_28 · Cited by 134
Ppars, metabolic disease and atherosclerosis
Fruchart, J., Staels, B., & Duriez, P. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0871 · Cited by 129
Tangier disease as a test of the reverse cholesterol transport hypothesis
Tall, A. R., & Wang, N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11538 · Cited by 125
Altman, R., Luciardi, H. L., Muntaner, J. A., Rio, F. D., Berman, S., López, R., & González, C. D. (2002) · Circulation · doi:10.1161/01.cir.0000021599.56755.a1 · Cited by 125
Savage, M. P., Goldberg, S., Bové, A. A., Deutsch, E., Vetrovec, G. W., Macdonald, R. G., Bass, T. A., Margolis, J. R., Whitworth, H. B., Taussig, A. S., et al. (1995) · Circulation · doi:10.1161/01.cir.92.11.3194 · Cited by 124
Nosjean, O., & Boutin, J. A. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00281-9 · Cited by 121
Hou, L., Sasaki, H., & Stashenko, P. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4681-4687.2000 · Cited by 117
LXRs: new therapeutic targets in atherosclerosis?
Joseph, S. B., & Tontonoz, P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00009-2 · Cited by 112
Differential Leukotriene Constrictor Responses in Human Atherosclerotic Coronary Arteries
Allen, S. P., Dashwood, M. R., Morrison, K. J. M., & Yacoub, M. H. (1998) · Circulation · doi:10.1161/01.cir.97.24.2406 · Cited by 112
Spanbroek, R., Hildner, M., Köhler, A., Müller, A., Zintl, F., Kühn, H., Rådmark, O., Samuelsson, B. O., & Habenicht, A. J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091076998 · Cited by 111
Sequestration of aggregated low-density lipoproteins by macrophages
Kruth, H. S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00003 · Cited by 111
Pontsler, A. V., Hilaire, A. S., Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109546200 · Cited by 110
Oxidized lipids as mediators of coronary heart disease
Navab, M., Hama, S. Y., Ready, S. T., Ng, C. J., Lenten, B. J. V., Laks, H., & Fogelman, A. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200208000-00003 · Cited by 110
Panini, S. R., Yang, L., Rusiñol, A. E., Sinensky, M. S., Bonventre, J. V., & Leslie, C. C. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32223-9 · Cited by 109
Lötzer, K., Spanbroek, R., Hildner, M., Urbach, A., Heller, R., Bretschneider, E., Galczenski, H., Evans, J. F., & Habenicht, A. J. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082690.23131.cb · Cited by 106
Natarajan, R. D., Gerrity, R. G., Gu, J., Lanting, L. L., Thomas, L. S., & Nadler, J. L. (2002) · Diabetologia · doi:10.1007/s125-002-8253-x · Cited by 101
Regulation of cell growth by oxidized LDL
Chisolm, G. M., & Chai, Y.-C. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00227-6 · Cited by 96
Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis
Deigner, H., Claus, R. A., Bonaterra, G. A., Gehrke, C., BIBAK, N., Blaess, M. F., Cantz, M., Metz, J., & Kinscherf, R. (2001) · The FASEB Journal · doi:10.1096/fasebj.15.3.807 · Cited by 92
Schumann, R. R., Rietschel, E. T., & Loppnow, H. (1994) · Medical Microbiology and Immunology · doi:10.1007/bf00196679 · Cited by 92
Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?
Fujino, H., & Regan, J. W. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00162-7 · Cited by 92
Ledwith, B. J., Pauley, C. J., Wagner, L. K., Rokos, C. L., Alberts, D. W., & Manam, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3707 · Cited by 90
Macrophage foam cells and atherosclerosis
Howard, S. K. (2001) · Frontiers in bioscience · doi:10.2741/kruth · Cited by 89
Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum
Mori, M., Itabe, H., Higashi, Y., Fujimoto, Y., Shiomi, M., Yoshizumi, M., Ouchi, Y., & Takano, T. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31503-0 · Cited by 88
Schäfer, K., Müller, K., Hecke, A., Mounier, E., Goebel, J., Loskutoff, D. J., & Konstantinides, S. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000097766.36623.df · Cited by 86
Gbaguidi, F., Chinetti, G., Milosavljevic, D., Morier-teissier, E., Chapman, J., Olivecrona, G., Fruchart, J., Griglio, S., Fruchart, J., & Staels, B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02223-8 · Cited by 84
Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home
Fitzgerald, M. L., Moore, K. J., & Freeman, M. W. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0318-y · Cited by 81
Vallvé, J.-C., Uliaque, K., Girona, J., Cabré, A., Ribalta, J., Heras, M., & Masana, L. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00046-1 · Cited by 78
New phospholipase A2 isozymes with a potential role in atherosclerosis
Murakami, M., & Kudo, I. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00003 · Cited by 77
Collins, R., Baignent, C., Sandercock, P. A., & Peto, R. (1994) · BMJ · doi:10.1136/bmj.309.6963.1215 · Cited by 76
Ardans, J. A., Economou, A. P., Martinson, J., Zhou, M., & Wahl, L. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.1012 · Cited by 72
Expression of lipoprotein receptors in atherosclerotic lesions
Hiltunen, T. P., & Ylä‐Herttuala, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00307-9 · Cited by 71
Oxidized Low Density Lipoprotein Decreases Macrophage Expression of Scavenger Receptor B-I
Han, J., NICHOLSON, A. C., Zhou, X., Feng, J., Gotto, A. M., & Hajjar, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011302200 · Cited by 70
Celotti, F., & Durand, T. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s1098-8823(03)00039-x · Cited by 69
Wang, M., & Tafuri, S. R. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10492 · Cited by 69
Tsukamoto, K., Kinoshita, M., Kojima, K., Mikuni, Y., Kudo, M., Mori, M., Fujita, M., Horie, E., Shimazu, N., & Teramoto, T. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.57 · Cited by 67
Selective Inhibition of Cytosolic Phospholipase A2 in Activated Human Monocytes
Li, Q., & Cathcart, M. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2404 · Cited by 61
Paul, A., Calleja, L., Camps, J., Osada, J., Vilella, E., Ferré, N., Mayayo, E., & Joven, J. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00950-4 · Cited by 60
Toll-like receptor 4 and atherogenesis
Kiechl, S. J., Wiedermann, C. J., & Willeit, J. (2003) · Annals of Medicine · doi:10.1080/07853890310008215 · Cited by 59
Is there a genetic basis for resistance to atherosclerosis?
Stein, O., Thiery, J., & Stein, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00664-5 · Cited by 57
Rangwala, S. M., & Lazar, M. A. (2002) · Science Signaling · doi:10.1126/stke.2002.121.pe9 · Cited by 57
Kwak, B. R., Myit, S., Mulhaupt, F., Veillard, N. R., Rufer, N., Roosnek, E. E., & Mach, F. (2002) · Circulation Research · doi:10.1161/hh0302.104924 · Cited by 56
Minimally Modified LDL Is an Oxidized LDL Enriched with Oxidized Phosphatidylcholines
Itabe, H. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg164 · Cited by 56
Lee, J. Y., & Hwang, D. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02530-5 · Cited by 55
van Berkel, T. J. C., Eck, M. V., Herijgers, N., Fluiter, K., & Nion, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06306.x · Cited by 54
Cyclooxygenase-2 and atherosclerosis
Linton, M. F., & Fazio, S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00005 · Cited by 52
Distinct scavenger receptor expression and function in the human CD14+/CD16+monocyte subset
Draude, G., von Hundelshausen, P., Frankenberger, M., Ziegler‐Heitbrock, H. W. L., & Weber, C. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.4.h1144 · Cited by 49
85-kDa cPLA2plays a critical role in PPAR-mediated gene transcription in human hepatoma cells
Han, C. L., Demetris, A. J., Michalopoulos, G. K., Shelhamer, J. H., & Wu, T. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00305.2001 · Cited by 48
The coming of age of our understanding of the enterohepatic circulation of bile salts
Redinger, R. N. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)01212-6 · Cited by 46
The lipid-laden foam cell: an elusive target for therapeutic intervention
Brewer, H. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9664 · Cited by 40
Eligini, S., Colli, S., Basso, F., Sironi, L., & Tremoli, E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1719 · Cited by 40
Sakashita, T., Takahashi, Y., Kinoshita, T., et al. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00803.x · Cited by 38
Akiba, S., Yoneda, Y., Ohno, S., Nemoto, M., & Sato, T. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300012-jlr200 · Cited by 38
Xu, W., Takahashi, Y., Sakashita, T., Iwasaki, T., Hattori, H., & Yoshimoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105093200 · Cited by 35
Leukocyte Recruitment Into Developing Atherosclerotic Lesions
Rosenfeld, M. E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.104847 · Cited by 35
Sequestration of aggregated LDL by macrophages studied with freeze-etch electron microscopy
Haberland, M. E., Mottino, G. A., Le, M. M., & Frank, J. S. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31170-6 · Cited by 33
Klappacher, G., & Glass, C. K. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00011 · Cited by 32
Cippitelli, M., Fionda, C., Bona, D. D., Lupo, A., Piccoli, M., Frati, L., & Santoni, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4578 · Cited by 31
LDL Stimulates Chemotaxis of Human Monocytes Through a Cyclooxygenase-Dependent Pathway
Kreuzer, J., Denger, S., Jahn, L., et al. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1481 · Cited by 31
Roles of peroxisome proliferator-activated receptor γ in cardiovascular disease
Takano, H., & Komuro, I. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00203-3 · Cited by 30
Evidence that increased 12-lipoxygenase activity induces apoptosis in fibroblasts
Gu, J., Liu, Y., Wen, Y., Natarajan, R. D., Lanting, L. L., & Nadler, J. L. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200103)186:3 · Cited by 27
Atherosclerosis in C3H/HeJ Mice Reconstituted With Apolipoprotein E-Null Bone Marrow
Shi, W., Wang, X., Tangchitpiyanond, K., Wong, J., Shi, Y.-S., & Lusis, A. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013388.03553.31 · Cited by 25
Uptake of oxidized low-density lipoprotein in a THP-1 cell line lacking scavenger receptor A
Sugano, R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00456-7 · Cited by 22
Current perspective on the cardiovascular effects of coxibs.
Konstam, M. A., & Weir, M. R. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_1.si47 · Cited by 22
van den Eijnden, M. M. E. D., van Noort, J. T., Hollaar, L., van der Laarse, A., & Bertina, R. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.384 · Cited by 21
Fair, A., & Pritchard, K. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1803 · Cited by 20
TP or Not TP: Primary Mediators in a Close Runoff?
Praticò, D., Cheng, Y., & FitzGerald, G. A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1695 · Cited by 18
Hayashida, K., Kume, N., Minami, M., Kataoka, H., Morimoto, M., & Kita, T. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03965.x · Cited by 14
Pharmacological evidence for a role of liver X receptors in atheroprotection
Kovanen, P. T., & Pentikäinen, M. O. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00011-5 · Cited by 13
Mathur, S. N., Albright, E., & Field, F. J. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90306-8 · Cited by 7
Cited by
The mystery of membrane organization: composition, regulation and roles of lipid rafts
Sezgin, E., Levental, I., Mayor, S., & Eggeling, C. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.16 · Cited by 2,124
Smoking and Cardiovascular Disease: Mechanisms of Endothelial Dysfunction and Early Atherogenesis
Messner, B., & Bernhard, D. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.300156 · Cited by 1,139
Autophagy Regulates Cholesterol Efflux from Macrophage Foam Cells via Lysosomal Acid Lipase
Ouimet, M., Franklin, V., Mak, E., Liao, X., Tabas, I., & Marcel, Y. L. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.023 · Cited by 774
Recent Advances on the Role of Cytokines in Atherosclerosis
Ait-Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207415 · Cited by 578
Monocyte and Macrophage Dynamics During Atherogenesis
Ley, K., Miller, Y. I., & Hedrick, C. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.221127 · Cited by 554
Self-citation
Metadata
- Authors
- Shashkin, P., Dragulev, B., & Ley, K.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-09-01
- Volume
- 11
- Issue
- 23
- Pages
- 3061-3072
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2123177387
- Cited by
- 295
- References
- 165
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.